Form 4: AVITA Medical CFO David O'Toole Acquires Shares

CFO David O'Toole acquired 2,000 shares of AVITA Medical common stock at a price of $3.97 per share.

Summary

• David O'Toole, CFO of AVITA Medical, Inc. (RCEL), acquired 2,000 shares of common stock.
• The transaction occurred on June 12, 2026.
• The purchase price was $3.97 per share.
• Following this transaction, the reporting person's total beneficial ownership is 152,927 shares, which includes unvested RSUs.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mildly positive signal, as it reflects internal confidence from the CFO, though the transaction size is relatively small compared to total outstanding shares.

Positives

• Insider confidence is demonstrated by the CFO increasing his equity stake in the company.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal of management's belief in the company's long-term valuation, particularly when executed by a C-suite executive.

Comparison to Industry Standards

• Insider purchases are standard corporate governance disclosures and align with typical executive compensation and equity ownership practices in the medical device sector.

Stakeholder Impact

• Shareholders may interpret this as a sign of management alignment with company performance.

Next Steps

• No further actions or milestones were disclosed in this filing.

Key Dates

Keywords

AVITA Medical, RCEL, Insider Trading, Form 4, CFO, Equity Acquisition